Navigation Links
BioMarin Announces Fourth Quarter and Full Year 2008 Financial Results
Date:2/18/2009

borative agreement revenues for the year ended December 31, 2008 were $38.9 million, compared to $28.3 million for the year ended December 31, 2007.

Impairment Loss on Investments

In the fourth quarter of 2008, BioMarin recorded an impairment charge of $4.1 million for the decline in the value of its equity investment in Summit Corporation plc. Based on the current market conditions, the low volume of trading in Summit securities and its current financial condition, BioMarin determined that its investment in Summit was impaired as of year end and adjusted the recorded amount of its investment to the stock's market price on December 31, 2008. The remaining investment in Summit Corporation plc. of $1.6 million is reflected on the balance sheet as of December 31, 2008.



    2009 Guidance
    Revenue Guidance ($ in millions)

    Item                                          2009 Guidance    2008 Actual
    Total BioMarin Revenues                       $307 to $336     $296.5
    Total Net Product Revenues                    $300 to $329     $251.9
    Naglazyme Net Product Revenue                 $160 to $175     $132.7
    Kuvan Net Product Revenue                     $70 to $80       $46.7
    Aldurazyme Net Product Revenue to BioMarin*   $69 to $74       $72.5


    *  The 2009 Aldurazyme guidance, as compared to 2008, reflects increased
       royalties earned offset by a reduction of $7 million to $9 million in
       net incremental product transfer revenue, mostly related to the initial
       inventory transfer.



    Selected Income Statement Guidance ($ in millions)

    Item                                       Guidance
    Cost of Sales (% of Total Revenue)         19% to 21%
    Selling, General and Admin. Expense        $120 to $130
    Research and Development Expense*          $110 to $120
    Costs Associated with Riquent Deal**       Up to $15
    Interest Income      
'/>"/>
SOURCE BioMarin Pharmaceutical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. BioMarin to Host Fourth Quarter and Full Year 2008 Financial Results Conference Call and Webcast on Wednesday, February 18 at 5:00 p.m. ET (23:00 CET)
2. BioMarin to Present at the Piper Jaffray Healthcare Conference
3. BioMarin Announces the Planned Retirement of Dr. Emil Kakkis, Chief Medical Officer
4. BioMarin to Present at the Credit Suisse Healthcare Conference
5. BioMarin Announces Third Quarter 2008 Financial Results
6. BioMarin Corrects Information Included in Bloomberg Article
7. BioMarin to Present at the Merrill Lynch Global Pharmaceutical Conference
8. BioMarin to Present at the Morgan Stanley Global Healthcare Conference
9. BioMarin to Present at the Citi Biotech Day
10. BioMarin Announces Roll-Out of National PKU Registry
11. BioMarin to Host Second Quarter 2008 Financial Results Conference Call and Webcast on Tuesday, August 5 at 5:00 p.m. ET (23:00 CET)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... San Diego, Calif. (PRWEB) June 02, 2015 ... developer of build-to-order, independent blade-based and rackmount computing ... centers, today announced the launch of its high ... offering, the Cirrascale Slipstreamâ„¢ RM1622D . The ... Xeon® processor E3-1200 v4 product family with Intel® ...
(Date:6/2/2015)... , June 2, 2015   Intrexon ... in synthetic biology, announced today the appointment of ... Vice President, Consumer Sector.  Mr. Jarry will lead ... in products and applications for consumer markets.  ... 30 years of experience in leading global life ...
(Date:6/2/2015)... Ohio , June 2, 2015 GOJO, ... pledged its commitment to antibiotic stewardship at the White ... human and animal health organizations and stakeholders at the ... five years to slow the emergence of antibiotic-resistant bacteria, ... antibiotics, and prevent the spread of resistant infections. ...
(Date:6/1/2015)... 02, 2015 Chosen for his ... Jack Uldrich has been selected as keynote speaker ... today. He will deliver his keynote: "Don't Stop ... delivered presentations to the American Medical Association, Blue ... Neurology, Alcetel-Lucent/Verizon Forum on Wireless Healthcare, United Healthcare, ...
Breaking Biology Technology:Cirrascale® Announces Support for Intel® Xeon® Processor E3-1200 v4 Product Family; Launches Server Offering Optimized for Low Cost-per-Stream Transcoding Applications 2Cirrascale® Announces Support for Intel® Xeon® Processor E3-1200 v4 Product Family; Launches Server Offering Optimized for Low Cost-per-Stream Transcoding Applications 3Intrexon Announces New Sector Leader 2Intrexon Announces New Sector Leader 3GOJO Among Leaders At The White House Forum On Antibiotic Stewardship 2GOJO Among Leaders At The White House Forum On Antibiotic Stewardship 3GOJO Among Leaders At The White House Forum On Antibiotic Stewardship 4Futurist Jack Uldrich to Address the Future of Pharmaceuticals 2
... Plant Biotechnology Industry, WILMINGTON, Del., Oct. 18 ... the best employers in the biotechnology and,pharmaceutical industry in ... is the first DuPont appearance on the survey,s top ... of other companies in the,plant biotechnology industry. DuPont also ...
... (Nasdaq: NPSP ) announced today the expiration and,final ... all of its outstanding,3.0% Convertible Notes due 2008. The ... October 17, 2007. As of the expiration date ... notes, representing approximately 99.7% of the notes,outstanding, had been ...
... Completes Enrollment in First Cohort --, SAN ... (TSX:NVN) today announced that the Company,has completed enrollment ... clinical trial,to assess the safety and tolerability of ... The trial is expected to dose up ...
Cached Biology Technology:DuPont Named Among Top Biotechnology Employers by Science Magazine 2NPS Pharmaceuticals Announces Results of Tender Offer 2NPS Pharmaceuticals Announces Results of Tender Offer 3Nventa updates progress of cervical dysplasia trial with new HspE7 2Nventa updates progress of cervical dysplasia trial with new HspE7 3Nventa updates progress of cervical dysplasia trial with new HspE7 4Nventa updates progress of cervical dysplasia trial with new HspE7 5
(Date:5/14/2015)... NEW YORK , May 14, 2015 ... specializing in identity verification and online remote ... Instructure, a software-as-a-service (SaaS) company and creator ... Shared customers of the two companies will ... Proctortrack in Canvas. As a ...
(Date:5/11/2015)... , May 11, 2015 Curemark LLC, a ... start of a new Phase III double blind, randomized, ... novel formulation, CM-AT, on all children ages 3-8 with ... FDA Phase III double blinded clinical trial for CM-AT ... levels of the digestive enzyme chymotrypsin. This new trial ...
(Date:5/7/2015)... Sweden , May 7, 2015 ... touch fingerprint sensors, FPC1022 and FPC1035, FPC,s smallest ... and FPC1035 are mainly considered for integration on ... size gives smartphone OEMs increased possibilities to integrate ... The decreased size also improves possibilities for module ...
Breaking Biology News(10 mins):Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2
... 2011 Metabolism encompasses the biochemical reactions that sustain ... systems: one that breaks down nutrients to generate energy ... building blocks cells need to thrive. Considering the fundamental ... metabolic dysfunctions can lead to serious diseases. ...
... progressively harder to navigate the maze of Los Angeles freeways. ... vehicle pollution, mice showed significant brain damage including signs ... toxin is not an exhaust gas, but a mix of ... car parts and pavement, according to the study to be ...
... Frequent reports of accelerating species losses invariably raise ... should work to conserve biodiversity. Biologists have traditionally ... are often presumed to be offered by biodiversity--benefits like ... and helping to purify air and water, among many ...
Cached Biology News:At EB2011: The role of metabolism in disease 2Freeway air bad for mouse brain 2Precedent-setting evidence of the benefits of biodiversity 2Precedent-setting evidence of the benefits of biodiversity 3Precedent-setting evidence of the benefits of biodiversity 4
... used as a fluorescent stain for nucleic ... orange at a concentration of 120 μM ... a sensitivity of 25-50 ng per band. ... cell staining of DNA in apoptosis studies. ...
... induced prior to DNA purification increasing DNA ... single-copy BACs with the high yields associated ... kits provide the linearized vector and associated ... necessary to create a 10X human BAC ...
... Templates rich in GC content or ... difficult to amplify, and when subjected to ... Yield, specificity and consistency can be increased ... PCR amplification reactions. Polymer-Aide is an effective ...
...
Biology Products: